Similar to results published in children with malignancy (67) and sepsis patients (66), we were able to observe increased MBL levels in COVID-19 individuals with wildtype MBL2 genes in our study, while this was not the case for individuals from the MBL low+deficient groups (Figure 6A). The gene discussed is MBL2; the disease is COVID-19.